In: Interactive CardioVascular and Thoracic Surgery, 2018, vol. 27, no. 4, p. 581-585
|
In: International Journal for Quality in Health Care, 2018, vol. 30, no. 4, p. 257-264
|
In: Interactive CardioVascular and Thoracic Surgery, 2017, vol. 25, no. 3, p. 384-390
|
In: Medizinische Klinik - Intensivmedizin und Notfallmedizin, ///-
|
In: Catheterization and Cardiovascular Interventions, 2019, p. ccd.28376
To evaluate the safety and efficacy outcomes after primary percutaneous coronary intervention (pPCI) with second‐generation Resolute™ zotarolimus‐eluting stent (R‐ ZES) in patients enrolled in the DAPT‐STEMI Trial (NCT01459627).Background: R‐ ZES is one of the most used drug eluting stents worldwide. To date, the safety and efficacy data of this stent in setting of STEMI is...
|
In: Cardiovascular Revascularization Medicine, 2019, vol. 20, no. 7, p. 577–582
Background: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential improvement in percutaneous coronary intervention (PCI) after the groundbreaking development of drug eluting stents (DES). However, the clinical performance, long-term safety and efficacy of BVS in complex coronary lesions remain uncertain. COMPARE ABSORB, a multicenter, single blind, prospective ...
|
In: Pediatric Cardiology, 2014, vol. 35, no. 5, p. 851-856
|
In: European Archives of Oto-Rhino-Laryngology, 2014, vol. 271, no. 9, p. 2355-2358
|
In: European Journal of Pediatrics, 2014, vol. 173, no. 8, p. 983-996
|
In: Pediatric Cardiology, 2014, vol. 35, no. 1, p. 71-76
|